CD8A and neoplasm: For example, enumeration of CD8+ tumor-infiltrating lymphocytes (TILs) has been shown to be a reliable prognostic marker for a number of cancers, including colorectal cancer and non–small-cell lung carcinoma (NSCLC) [3, 21, 23, 24, 28].